Physician profile
Ryan Adams Metcalf
NPI 1437555935
$45,279.37
in general payments reported to CMS, 2019-2025
3 companies · $7,643 in 2025
The $7,643 reported for 2025 was more than what 94% of Anatomic Pathology & Clinical Pathology providers received nationally (typical 2025 total: $50.59).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $38K · 2025: $7,643.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $30K · Consulting Fee: $5,400 · Travel and Lodging: $4,961 · Honoraria: $3,500 · Food and Beverage: $1,279 · Gift: $112 · Entertainment: $27.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $30,000.00 |
| Consulting Fee | $5,400.00 |
| Travel and Lodging | $4,960.93 |
| Honoraria | $3,500.00 |
| Food and Beverage | $1,279.13 |
| Gift | $112.31 |
| Entertainment | $27.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Octapharma USA, INC. | $30,000.00 | 2024 | Fibryga |
| Cerus Corporation | $7,642.94 | 2025 | Intercept Blood System For Platelets |
| Instrumentation Laboratory Company | $7,636.43 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Metcalf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.